Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $36.3600 (-3.32%) ($35.9000 - $37.5800) on Mon. Oct. 19, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.87% (three month average) | RSI | 60 | Latest Price | $36.3600(-3.32%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA advances 3.1% a day on average for past five trading days. | Weekly Trend | IOVA advances 5.6% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(47%) XBI(45%) ARKG(43%) IWO(41%) ARKK(39%) | Factors Impacting IOVA price | IOVA will decline at least -1.935% in a week (0% probabilities). VIXM(-23%) UUP(-16%) VXX(-12%) TBT(-6%) UNG(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.935% (StdDev 3.87%) | Hourly BBV | -0.6 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $35.42(2.65%) | 10 Day Moving Average | $32.7(11.19%) | 20 Day Moving Average | $32.54(11.74%) | To recent high | -3.3% | To recent low | 31% | Market Cap | $5.324b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |